María José Sevilla-Sánchez

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 6

Top Topics

Escherichia Coli

Induced Apoptosis

Psychometric Properties

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Alejandro Montoya-Gómez, Fiorella Tonello, Barbara Spolaore, Maria Lina Massimino, Leonel Ives Montealegre-Sanchez, Andrés Castillo, Nelson Rivera Franco, María José Sevilla-Sánchez, Luis Manuel Solano-Redondo, Mildrey Mosquera-Escudero, Eliécer Jiménez-Charris
Pllans-II : Unveiling the Action Mechanism of a Promising Chemotherapeutic Agent Targeting Cervical Cancer Cell Adhesion and Survival Pathways. Cells 12 (23) (2023)
María José Sevilla-Sánchez, Alejandro Montoya-Gómez, Daniel Osorno-Valencia, Leonel Ives Montealegre-Sanchez, Mildrey Mosquera-Escudero, Eliécer Jiménez-Charris
Exploring the Safety of Pllans-II and Antitumoral Potential of Its Recombinant Isoform in Cervical Cancer Therapy. Cells 12 (24) (2023)
María José Sevilla-Sánchez, Alejandro Montoya-Gómez, Daniel Osorno-Valencia, Leonel Ives Montealegre-Sanchez, Mildrey Mosquera-Escudero, Eliécer Jiménez-Charris
Exploring the Safety of Pllans-II and Antitumoral Potential of Its Recombinant Isoform in Cervical Cancer Therapy. Cells 12 (24) (2023)
María José Sevilla-Sánchez, Alejandro Montoya-Gómez, Daniel Osorno-Valencia, Leonel Ives Montealegre-Sanchez, Mildrey Mosquera-Escudero, Eliécer Jiménez-Charris
Exploring the Safety of Pllans-II and Antitumoral Potential of Its Recombinant Isoform in Cervical Cancer Therapy. Cells 12 (24) (2023)
María José Sevilla-Sánchez, Alejandro Montoya-Gómez, Daniel Osorno-Valencia, Leonel Ives Montealegre-Sanchez, Mildrey Mosquera-Escudero, Eliécer Jiménez-Charris
Exploring the Safety of Pllans-II and Antitumoral Potential of Its Recombinant Isoform in Cervical Cancer Therapy. Cells 12 (24) (2023)
María José Sevilla-Sánchez, Alejandro Montoya-Gómez, Daniel Osorno-Valencia, Leonel Ives Montealegre-Sanchez, Mildrey Mosquera-Escudero, Eliécer Jiménez-Charris
Exploring the Safety of Pllans-II and Antitumoral Potential of Its Recombinant Isoform in Cervical Cancer Therapy. Cells 12 (24) (2023)